Uncategorized
FDA lifts MacroGenics hold; Oxford and Bristol Myers team up
FDA lifts MacroGenics hold; Oxford and Bristol Myers team up
Plus, news about Boston Oncology, Garda and Assertio, an Everest deal and Forte’s raise:
🟢 FDA ends partial hold on MacroGenics cancer drug: In February, the agency stopped a Phase 2 trial of lorigerlimab after … Read More